title: Treating the mother, protecting the unborn: the motherisk approach.
abstract: Pregnant women and their unborn babies are excluded from most pharmaceutical research. We have to convince regulatory agencies worldwide that, by not demanding research of drug safety and effectiveness in pregnancy from pharmaceutical agencies, we are orphaning pregnant women from progress in therapeutics and causing both themselves and their unborn babies tremendous unacceptable risks.
authors.affiliation: The Motherisk Program, Division of Clinical Pharmacology, the Hospital for Sick Children, Toronto, Canada.
authors.forename: Gideon
authors.initials: G
authors.lastname: Koren
keywords: drugs; fetus; knowledge transfer; pregnancy; safety; toxicity